191 Street Georges Terrace
Level 5
Perth, WA 6000
Australia
61 2 8072 1400
https://www.osteopore.com
Secteur(s): Healthcare
Secteur d’activité: Medical Instruments & Supplies
Employés à temps plein:
Nom | Titre | Payer | Exercé | Année de naissance |
---|---|---|---|---|
Mr. Kei Wei Leong | Executive Chairman | 150k | S.O. | 1976 |
Dr. Yujing Lim | CEO & CTO | 202,25k | S.O. | S.O. |
Ms. Shu Ning Voon | Financial Controller | S.O. | S.O. | S.O. |
Mr. Khoon Seng Goh | Global Marketing Director | 212,9k | S.O. | S.O. |
Ms. Kellie Davis | Company Secretary | S.O. | S.O. | S.O. |
Osteopore Limited, a regenerative medicine company, engages in the production of 3D-printed biomimetic and bioresorbable implants in Vietnam, South Korea, the Philippines, Singapore, the United States, Malaysia, Indonesia, Netherlands, South Africa, Thailand, and internationally. The company commercializes a range of bespoke products to facilitate bone healing across multiple therapeutic areas. Its technology fabricates specific micro-structured scaffolds for bone regeneration through 3D printing and bioresorbable material. It manufactures and trades medical implants. In addition, it sells medical devices; provides technology services; and engages in research and development. Osteopore Limited was incorporated in 2018 and is headquartered in Perth, Australia.
L’ISS Governance QualityScore de Osteopore Limited en date du S.O. est S.O.. Les scores principaux sont Audit : S.O.; Société : S.O.; Droits des actionnaires : S.O.; Compensation : S.O..